Literature DB >> 27859596

Osteosarcoma in a Patient With Pseudohypoparathyroidism Type 1b Due to Paternal Uniparental Disomy of Chromosome 20q.

Hye-Sun Park1, Chang Gon Kim2, Namki Hong1, Seok Joo Lee3, Da Hea Seo1, Yumie Rhee1.   

Abstract

It is assumed that a persistent high level of parathyroid hormone (PTH) might have a relation with bone malignancy. However, there has been no report of osteosarcoma associated with pseudohypoparathyroidism type 1b (PHP1b), which is accompanied by high PTH. PHP1b is the result of resistance to PTH in certain end-organ tissues, especially the kidney; the response in bone is unaffected because it normally expresses stimulatory G protein equally from both parental alleles. A 21-year-old male, presenting with gum swelling at the right mandible, was referred to a dental clinic. A curative surgical resection by segmental mandibulectomy was performed and the pathologic findings of the mass were consistent with osteoblastic osteosarcoma. His laboratory results showed a low calcium level despite high PTH, and he did not have any features of Albright hereditary osteodystrophy; therefore, PHP1b was suspected. Multiplex ligation-dependent probe amplification and microsatellite marker analyses of chromosome 20 confirmed the diagnosis and identified paternal uniparental disomy of chromosome 20q (patUPD20). To the best of our knowledge, this is the first report of osteosarcoma in a patient with PHP1b due to patUPD20.
© 2017 American Society for Bone and Mineral Research. © 2017 American Society for Bone and Mineral Research.

Entities:  

Keywords:  PARATHYROID-RELATED DISORDERS; PRIMARY TUMORS OF BONE AND CARTILAGE; PTH/VIT D/FGF23

Mesh:

Year:  2017        PMID: 27859596     DOI: 10.1002/jbmr.3043

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  A novel deletion involving GNAS exon 1 causes PHP1A and further refines the region required for normal methylation at exon A/B.

Authors:  Monica Reyes; Anara Karaca; Murat Bastepe; Nese Ersoz Gulcelik; Harald Jüppner
Journal:  Bone       Date:  2017-07-12       Impact factor: 4.398

2.  High frequency of paternal iso or heterodisomy at chromosome 20 associated with sporadic pseudohypoparathyroidism 1B.

Authors:  Cindy Colson; Matthieu Decamp; Nicolas Gruchy; Nadia Coudray; Céline Ballandonne; Claire Bracquemart; Arnaud Molin; Hervé Mittre; Rieko Takatani; Harald Jüppner; Marie-Laure Kottler; Nicolas Richard
Journal:  Bone       Date:  2019-03-21       Impact factor: 4.398

3.  Ponicidin Treatment Improved the Cell Proliferation, Differentiation, and Calcium Mineralization on the Osteoblast-Like MG-63 Cells.

Authors:  Yan Zhang; Pan Hao; Huilian Li; Bo Miao
Journal:  Appl Biochem Biotechnol       Date:  2022-05-12       Impact factor: 3.094

4.  12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.

Authors:  Emel Rothzerg; Jiake Xu; David Wood; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

5.  Aucubin exerts anti-osteoporotic effects by promoting osteoblast differentiation.

Authors:  Yutong Li; Yongfeng Zhang; Xinrui Zhang; Wenqian Lu; Xin Liu; Min Hu; Di Wang
Journal:  Aging (Albany NY)       Date:  2020-02-05       Impact factor: 5.682

6.  Paternal Uniparental Disomy of the Entire Chromosome 20 in a Child with Beckwith-Wiedemann Syndrome.

Authors:  Sanaa Choufani; Jung Min Ko; Youliang Lou; Cheryl Shuman; Leona Fishman; Rosanna Weksberg
Journal:  Genes (Basel)       Date:  2021-01-27       Impact factor: 4.096

Review 7.  Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement.

Authors:  Giovanna Mantovani; Murat Bastepe; David Monk; Luisa de Sanctis; Susanne Thiele; Alessia Usardi; S Faisal Ahmed; Roberto Bufo; Timothée Choplin; Gianpaolo De Filippo; Guillemette Devernois; Thomas Eggermann; Francesca M Elli; Kathleen Freson; Aurora García Ramirez; Emily L Germain-Lee; Lionel Groussin; Neveen Hamdy; Patrick Hanna; Olaf Hiort; Harald Jüppner; Peter Kamenický; Nina Knight; Marie-Laure Kottler; Elvire Le Norcy; Beatriz Lecumberri; Michael A Levine; Outi Mäkitie; Regina Martin; Gabriel Ángel Martos-Moreno; Masanori Minagawa; Philip Murray; Arrate Pereda; Robert Pignolo; Lars Rejnmark; Rebecca Rodado; Anya Rothenbuhler; Vrinda Saraff; Ashley H Shoemaker; Eileen M Shore; Caroline Silve; Serap Turan; Philip Woods; M Carola Zillikens; Guiomar Perez de Nanclares; Agnès Linglart
Journal:  Nat Rev Endocrinol       Date:  2018-08       Impact factor: 43.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.